Table 3.

Change in FBG from baseline to multiple end line intervals for participants enrolled in diabetes management programme

	Total observations				Observations for participants without history of diabetes		Observations for participants with history of diabetes
	Unadjusted		Adjusted		Adjusted		Adjusted
Period§	n	Change in FBG, mg/dL (95% CI)¶	n	Change in FBG, mg/dL (95% CI)¶	n	Change in FBG, mg/dL (95% CI)¶	n	Change in FBG, mg/dL (95% CI)¶
Period 1	3198	−13.9 (−19.5 to −8.2)	3198	−14.0 (−18.1 to −10.0)	859	−20.7 (−27.1 to −14.4)	2339	−11.8 (−16.7 to −7.0)
Period 2	2189	−18.9 (−25.5 to −12.4)	2189	−18.8 (−24.0 to −13.5)	612	−26.2 (−35.7 to −16.6)	1577	−15.4 (−21.5 to −9.4)
Period 3	1219	−16.7 (−25.6 to −7.7)	1219	−18.0 (−25.1 to −10.9)	291	−24.4 (−35.8 to −13.0)	928	−16.4 (−24.6 to −8.2)
Period 4	706	−20.4 (−32.6 to −8.2)†	706	−20.2 (−29.6 to −10.9)	183	−21.0 (−36.1 to −5.8)‡	523	−20.1 (−30.8 to −9.4)
Period 5	380	−26.8 (−43.3 to −10.4)†	380	−26.4 (−39.3 to −13.6)	105	−10.9 (−29.1 to 7.4)	275	−32.3 (−47.7 to −17.0)
Period 6	160	−15.8 (−42.8 to 11.3)	160	−27.9 (−47.6 to −8.1)‡	43	−16.5 (−42.5 to 9.4)	117	−33.7 (−58.7 to −8.6)†

Adjusted for age groups, gender, baseline FBG, BMI, hypertension, family history of diabetes.

*P<0.001.

†P<0.01.

‡P<0.05.

§All observations recorded between 31th–189th day from start date were grouped in period 1, 190th–378th day in period 2, 379th–566th day in period 3, 567th–755th day in period 4, 756th–943th day in period 5–944th to till end of the study period in period 6.

¶Difference in mean change; a negative change indicates a fall in average from baseline to end line.

BMI, body mass index; FBG, fasting blood glucose.